Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
Schmitz, M., Diestelkoetter, P., Weigle, B., Schmachtenberg, F., Stevanovic, S.,
Ockert, D., Rammensee, HG and Rieber, EP. (2000). Generation of survivin-
specific CD8+ T effector cells by dendritic cells pulsed with protein or selected
peptides. Cancer Res. 60: 4845-4849.
Schoenberger, SP, Toes, RE, van der Voort, EI, Offringa, R. and Melief, CJ
(1998). T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L
interactions. Nature 393: 480-483.
Schubert, LA, Jeffery, E., Zhang, Y., Ramsdell, F. and Ziegler, SF (2001). Scurfin
(FOXP3) acts as a repressor of transcription and regulates T cell activation. J.
Biol. Chem. 276(40): 37672-37679.
Schuler-Thurner, B., Schultz, ES, Berger, TG, Weinlich, G., Ebner, S., Woerl, P.,
Bender, A., Feuerstein, B., Fritsch, PO, Romani, N. and Schuler, G. (2002).
Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic
Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-
loaded Monocyte-derived Dendritic Cells. J. Exp. Med. 195: 1279-1288.
Schultze, JL and Vonderheide, RH (2001). From cancer genomics to cancer
immunotherapy: toward second-generation tumor antigens. Trends Immunol.
22: 516-523.
Seliger, B., Maeurer, MJ and Ferrone, S. (1997). TAP off-tumors on. Immunol.
Today 18: 292-299.
Seliger, B., Maeurer, MJ and Ferrone, S. (2000). Antigen-processing machinery
breakdown and tumor growth. Immunol. Today 21: 455-464.
Shevach, EM (2002). CD4+CD25+ suppressor T cells: more questions than
answers. Nat. Rev. Immunol. 2: 389-400.
119